Literature DB >> 11287508

Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome.

S Y Song1, J W Chung, J K Han, H G Lim, Y H Koh, J H Park, H S Lee, C Y Kim.   

Abstract

PURPOSE: To evaluate the incidence of, predisposing factors for, and clinical outcome of liver abscess developing in patients with hepatic tumors after transcatheter oily chemoembolization (TOCE).
MATERIALS AND METHODS: During the past 6-year period, 2,439 patients with hepatic tumors underwent a total of 6,255 TOCE procedures. With a retrospective review of medical records, the authors evaluated the occurrence of liver abscess, the statistical significance of potential predisposing factors including portal vein obstruction, metastatic tumors, biliary abnormalities (type 1, simple biliary obstruction; type 2, status prone to ascending biliary infection), malignant gastrointestinal mucosal lesions, and additional gelatin sponge particle embolization in liver abscess formation, and the clinical outcome of abscess.
RESULTS: Fifteen liver abscesses occurred in 14 patients (0.2%). Liver abscesses developed in three of 987 (0.3%) TOCE procedures for portal vein obstruction, three of 114 (2.6%) procedures for metastatic tumors, one of 49 (1.8%) for type 1 biliary abnormality, four of 55 (7.4%) for type 2 biliary abnormality, two of 18 (11.1%) for malignant gastrointestinal mucosal lesion, and nine of 2,108 (0.4%) for additional gelatin sponge particle embolization. Univariate and multivariate statistical analysis showed that type 2 biliary abnormality was a significant predisposing factor. The mortality related to liver abscess occurred in two patients (13.3%). Thirteen liver abscesses were successfully treated with parenteral antibiotics and percutaneous catheter drainage. However, irreversible deterioration of liver function occurred in two patients. Two of nine further TOCE procedures in three patients caused recurrent septicemia and liver abscess.
CONCLUSION: The biliary abnormality prone to ascending biliary infection was the most important predisposing factor to the development of liver abscess after TOCE. Postembolic liver abscess could be effectively managed with percutaneous catheter drainage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287508     DOI: 10.1016/s1051-0443(07)61910-1

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  30 in total

1.  Antibiotic prophylaxis in transarterial therapy of hepatocellular carcinoma: a meta-analysis.

Authors:  Jun Wang; Xiao Dong He; You Cheng Zhang
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

2.  Liver abscess as a complication of hepatic transarterial chemoembolization: a case report, literature review, and clinical recommendations.

Authors:  Ari M Vanderwalde; Howard Marx; Lucille Leong
Journal:  Gastrointest Cancer Res       Date:  2009-11

Review 3.  Bland Liver Tumor Embolization Complicated by Hepatic Abscess.

Authors:  Omar H Elsayed-Ali; Andrew J Lipnik; Daniel B Brown
Journal:  Semin Intervent Radiol       Date:  2015-09       Impact factor: 1.513

4.  Prophylactic antibiotic guidelines in modern interventional radiology practice.

Authors:  Eunice Moon; Matthew D B S Tam; Raghid N Kikano; Karunakaravel Karuppasamy
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

5.  Liver abscess following transarterial chemoembolization.

Authors:  Danny Cheng
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

6.  Hepatic abscess with biliary communication following transarterial chemoembolization of hepatocellular carcinoma.

Authors:  Robert J Huang; Andrew P Ambrosy; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2013-02-20       Impact factor: 3.199

7.  [Transarterial ablation of hepatocellular carcinoma. Status and developments].

Authors:  B A Radeleff; U Stampfl; C M Sommer; N Bellemann; K Hoffmann; T Ganten; R Ehehalt; H U Kauczor
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

8.  Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.

Authors:  Thomas Vogl; Katrin Eichler; Stephan Zangos; Christopher Herzog; Renate Hammerstingl; Jörn Balzer; Ali Gholami
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-05       Impact factor: 4.553

9.  Liver abscess following radioembolization with yttrium-90 microspheres.

Authors:  Mehmet Korkmaz; Halil Bozkaya; Celal Çınar; Bekir Şanal; Serkan Güneyli; Mustafa Parıldar; İsmail Oran
Journal:  Wien Klin Wochenschr       Date:  2014-09-19       Impact factor: 1.704

Review 10.  The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Authors:  Sung Wook Shin
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.